{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.05",
    "chg": -0.01,
    "chgp": "-0.94%",
    "dir": -1,
    "prev_price": "1.06",
    "mcapval": "59.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE861N01036",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "3.32 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 14,
    "sid": "329838",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 11Th August 2026.",
      "datetime": "03-Aug-2026",
      "details": "Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. To consider and approve Un-audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 30th June 2026. 2. To consider any other business with the permission of a Chairman.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News